Microarray based STR genotyping utilizing RecA-mediated ligation

Information

  • Research Project
  • 8098886
  • ApplicationId
    8098886
  • Core Project Number
    R44HG004679
  • Full Project Number
    5R44HG004679-03
  • Serial Number
    4679
  • FOA Number
    PA-09-080
  • Sub Project Id
  • Project Start Date
    5/1/2008 - 16 years ago
  • Project End Date
    9/30/2012 - 12 years ago
  • Program Officer Name
    OZENBERGER, BRADLEY
  • Budget Start Date
    7/1/2011 - 13 years ago
  • Budget End Date
    9/30/2012 - 12 years ago
  • Fiscal Year
    2011
  • Support Year
    3
  • Suffix
  • Award Notice Date
    6/27/2011 - 13 years ago
Organizations

Microarray based STR genotyping utilizing RecA-mediated ligation

DESCRIPTION (provided by applicant): Tandem repeat sequences (STR) are distributed widely in the human genome. These sites exhibit high levels of length polymorphism as a result of their relative instability during DNA replication, i.e., the tendency for slippage to occur between the template and newly synthesized strands causing deletion or addition of repeat units. Changes in STR repeat number can lead to heritable genetic predispositions and disease. However, their variability makes them ideal markers for genetic studies. One class, the microsatellites containing 4 base pair repeat units, has been selected by the FBI as the basis for a genetic identification system, termed CODIS. Current analysis systems require a 1-2 day assay and employ electrophoretic separation of DNA fragments that contain the STR locus for accurate sizing and identification of the repeat number. The long-term goal of this project is to develop a simple, cost-effective and automatable assay system for STR analysis that allows human identification in less than 3 hours from sample to result by avoiding the need for PCR amplification, target DNA denaturation and electrophoretic separation. In Phase I of this proposal a single locus (TPOX) was used to demonstrate that accurate microarray based STR analysis is technically feasible and sufficiently rapid. In Phase II we will expand this assay to include at least 6 other CODIS loci, convert the technology from an in solution to an immobilized format and attempt to increase assay speed and convenience further by eliminating the PCR step. Our approach to achieving these goals utilizes Gene Check's RecA mediated ligation (RML) technology in which the extreme precision of RecA mediated homology searching in double stranded DNA is used to catalyze specific base pairing of oligonucleotide probes at the STR locus with subsequent ligation into specific products that reflect the length of the STR locus. Gene Check has discovered that RML can operate efficiently when one of the oligonucleotides is immobilized to a microarray slide, making high order multiplexing of the RML-STR technology feasible and practical. Signal amplification methods will be employed to allow genotyping directly from double stranded genomic DNA. Success in this project will produce an STR panel that can immediately be used in forensic applications as well as in human paternity and identity testing. The RML-STR system can readily be adapted to livestock, companion animal and wild animal parentage and identity testing and has potential application to diagnosis of medical conditions related to microsattelite sequence expansion. PUBLIC HEALTH RELEVANCE: Gene Check proposes to utilize its RecA mediated ligation technology for STR genotyping (RML-STR) in a microarray format to allow robust, rapid, low cost and automated STR genotyping. This system will be useful for personnel identification in everyday police investigations as well as in a variety of other forensic and non-human identification applications. Medical applications include tissue typing and genetic analysis of triplet repeat associated disorders.

IC Name
NATIONAL HUMAN GENOME RESEARCH INSTITUTE
  • Activity
    R44
  • Administering IC
    HG
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    387423
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    172
  • Ed Inst. Type
  • Funding ICs
    NHGRI:387423\
  • Funding Mechanism
    SBIR-STTR
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    GENE CHECK, INC.
  • Organization Department
  • Organization DUNS
    878414531
  • Organization City
    Greeley
  • Organization State
    CO
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    806344807
  • Organization District
    UNITED STATES